Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk

INTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk...

Full description

Bibliographic Details
Main Authors: Serhat Imamoglu, Nimet Yesim Ercalik, Buse Guneri Beser, Nimet Burcu Celik
Format: Article
Language:English
Published: KARE Publishing 2019-08-01
Series:Beyoglu Eye Journal
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710
id doaj-4cf7cab1c88a4878953dea2e15895202
record_format Article
spelling doaj-4cf7cab1c88a4878953dea2e158952022021-01-24T17:50:15ZengKARE PublishingBeyoglu Eye Journal2587-03942019-08-014211511910.14744/bej.2019.00710BEJ-00710Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation RiskSerhat Imamoglu0Nimet Yesim Ercalik1Buse Guneri Beser2Nimet Burcu Celik3Department of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyINTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk who underwent AGV implantation at a single institution were included in this retrospective study. The patients' preoperative intraocular pressure (IOP), best corrected visual acuity (BCVA), and the number of anti-glaucomatous eye drop medications used was compared with postoperative values. The success criteria were defined as a postoperative IOP of 5 to 21 mmHg and no loss of light perception.[¤]RESULTS[|]Twenty-three eyes of 23 (16 male, 7 female) patients were included in the study. The mean age of the patients was 64.6+-14.6 years and the mean follow-up period was 15.8+-8.3 months. The preoperative mean IOP was reduced from 33.6+-9.1 mmHg to 16.9+-5.1 mmHg at the last follow-up (p=0.000). The mean preoperative number of anti-glaucomatous eye drop medications used was 3.5+-1.3. Postoperatively the mean was 1.7+-1.4 at the last follow-up (p=0.000). The rate of total success was determined to be 78%. The postoperative mean BCVA did not change significantly. One patient lost light perception. A decrease in corneal clarity was observed in only 1 patient (4.3%). The postoperative complications observed were: bleb encapsulation (43%), hyphema (39%), tube occlusion (13%), choroidal detachment (8.7%), decompression retinopathy (8.7%), and corneal decompensation (4.3%).[¤]DISCUSSION AND CONCLUSION[|]Ciliary sulcus implantation of an AGV was effective, both in terms of IOP and the decrease in anti-glaucomatous drug use in the short term. This technique may be a good choice in patients with a corneal decompensation risk due to the posterior chamber implantation.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710ahmed glaucoma valveciliary sulcuscorneal decompensation.
collection DOAJ
language English
format Article
sources DOAJ
author Serhat Imamoglu
Nimet Yesim Ercalik
Buse Guneri Beser
Nimet Burcu Celik
spellingShingle Serhat Imamoglu
Nimet Yesim Ercalik
Buse Guneri Beser
Nimet Burcu Celik
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
Beyoglu Eye Journal
ahmed glaucoma valve
ciliary sulcus
corneal decompensation.
author_facet Serhat Imamoglu
Nimet Yesim Ercalik
Buse Guneri Beser
Nimet Burcu Celik
author_sort Serhat Imamoglu
title Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
title_short Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
title_full Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
title_fullStr Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
title_full_unstemmed Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
title_sort ciliary sulcus implantation of ahmed glaucoma valve in patients with corneal decompensation risk
publisher KARE Publishing
series Beyoglu Eye Journal
issn 2587-0394
publishDate 2019-08-01
description INTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk who underwent AGV implantation at a single institution were included in this retrospective study. The patients' preoperative intraocular pressure (IOP), best corrected visual acuity (BCVA), and the number of anti-glaucomatous eye drop medications used was compared with postoperative values. The success criteria were defined as a postoperative IOP of 5 to 21 mmHg and no loss of light perception.[¤]RESULTS[|]Twenty-three eyes of 23 (16 male, 7 female) patients were included in the study. The mean age of the patients was 64.6+-14.6 years and the mean follow-up period was 15.8+-8.3 months. The preoperative mean IOP was reduced from 33.6+-9.1 mmHg to 16.9+-5.1 mmHg at the last follow-up (p=0.000). The mean preoperative number of anti-glaucomatous eye drop medications used was 3.5+-1.3. Postoperatively the mean was 1.7+-1.4 at the last follow-up (p=0.000). The rate of total success was determined to be 78%. The postoperative mean BCVA did not change significantly. One patient lost light perception. A decrease in corneal clarity was observed in only 1 patient (4.3%). The postoperative complications observed were: bleb encapsulation (43%), hyphema (39%), tube occlusion (13%), choroidal detachment (8.7%), decompression retinopathy (8.7%), and corneal decompensation (4.3%).[¤]DISCUSSION AND CONCLUSION[|]Ciliary sulcus implantation of an AGV was effective, both in terms of IOP and the decrease in anti-glaucomatous drug use in the short term. This technique may be a good choice in patients with a corneal decompensation risk due to the posterior chamber implantation.[¤]
topic ahmed glaucoma valve
ciliary sulcus
corneal decompensation.
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710
work_keys_str_mv AT serhatimamoglu ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk
AT nimetyesimercalik ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk
AT buseguneribeser ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk
AT nimetburcucelik ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk
_version_ 1724325236084572160